Nippon India Pharma Fund (Bonus) Equity - Pharma
Plan: OPEN | Option: Growth | Sailesh Raj Bhan
25 Jul 24 | 12:00 AM
473.72 2.48 (0.53%)
Critical Parameters
Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.
Returns
In last 1 year Nippon India Pharma Fund (Bonus), has beaten by -6.22% (CAGR difference)
42.10%
Underperforms
This is Alpha
27 Jul 2023
Risk
In last 1 year , the volatility of Nippon India Pharma Fund (Bonus) is Lower than by -0.16%
0.74%
Less Volatile
Risk Meter
Consistency
For 4 out of Last 10 Months, i.e 40% of the times It beaten its benchmark, Equity - Pharma
Consistency Meter
Outperforming Stocks Vs. Underperforming Stocks
Based on the last 1year analysis, currently there are, the benchmark the benchmark